[Controlled comparative trial of acebutolol and bendrofluazide alone or in association for the treatment of hypertension]. 1975

D Wheatley

The hypotensive effects of acebutolol and bendrofluazide were studied comparatively, used alone or in association, using a permutation method over three consecutive six week periods, in 47 patients aged over 21 whose diastolic pressure prior to treatment was in excess of 100 mm Hg. Whether used alone or associated, the drugs were prescribed at the following daily doses: acebutolol 500 mg, bendrofluazide 5-15 mg. After six weeks and at the end of the trials (18 weeks), acebutolol proved to have an hypotensive effect, less marked when given alone than in association. It provided significant relief from anxiety, especially when prescribed alone during the latter part of the test. Side effects were unfrequent on the whole and without marked predominance for any type of treatment.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000070 Acebutolol A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action. Acebutolol Hydrochloride,Acetobutolol,Apo-Acebutolol,M & B 17803A,M&B-17803 A,Monitan,Neptal,Novo-Acebutolol,Prent,Rhotral,Sectral,Apo Acebutolol,ApoAcebutolol,M&B 17803 A,M&B17803 A,Novo Acebutolol,NovoAcebutolol
D001007 Anxiety Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS. Angst,Anxiousness,Hypervigilance,Nervousness,Social Anxiety,Anxieties, Social,Anxiety, Social,Social Anxieties
D001539 Bendroflumethiazide A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810) Bendrofluazide,Aprinox,Benzide,Benzide-M,Berkozide,Centyl,Esberizid,Naturetin,Naturine,Neo-NaClex,Pluryl,Urizid,Benzide M,Neo NaClex

Related Publications

D Wheatley
October 1977, European journal of clinical pharmacology,
D Wheatley
September 1974, British heart journal,
D Wheatley
January 1994, Current medical research and opinion,
D Wheatley
October 1979, The Journal of the Royal College of General Practitioners,
D Wheatley
January 1978, The Journal of international medical research,
Copied contents to your clipboard!